China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Research Report Forecast 2017 to 2022

July 2017 | 114 pages | ID: CDC2AE6574BEN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:
Acrostak (Schweiz) AG
Concept Medical Inc
Lifetech Scientific
Micell Technologies, Inc
SurModics, Inc.
The Spectranetics Corporation
Vascular Nanotransfer Technologies Company
company 8
company 9

China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market: Product Segment Analysis
Type 1
Type 2
Type 3

China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON (DEB) CATHETER MARKET OVERVIEW

1.1 Product Overview and Scope of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter
1.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Segmentation by Type
  1.2.1 China Production Market Share of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter by Type in 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Segmentation by Application
  1.3.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter (2012-2021)

CHAPTER 2 CHINA ECONOMIC IMPACT ON PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON (DEB) CATHETER INDUSTRY

2.1 China Macroeconomic Environment Analysis
  2.1.1 China Macroeconomic Analysis
  2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Industry

CHAPTER 3 CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON (DEB) CATHETER MARKET COMPETITION BY MANUFACTURERS

3.1 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production and Share by Manufacturers (2015 and 2016)
3.2 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Manufacturing Base Distribution, Production Area and Product Type
3.5 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Competitive Situation and Trends
  3.5.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Concentration Rate
  3.5.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON (DEB) CATHETER CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)

4.1 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Capacity, Production and Growth (2012-2017)
4.2 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Revenue and Growth (2012-2017)
4.3 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production, Consumption, Export and Import (2012-2017)

CHAPTER 5 CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON (DEB) CATHETER PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production and Market Share by Type (2012-2017)
5.2 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Revenue and Market Share by Type (2012-2017)
5.3 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Price by Type (2012-2017)
5.4 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production Growth by Type (2012-2017)

CHAPTER 6 CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON (DEB) CATHETER MARKET ANALYSIS BY APPLICATION

6.1 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Consumption and Market Share by Application (2012-2017)
6.2 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

CHAPTER 7 CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON (DEB) CATHETER MANUFACTURERS ANALYSIS

7.1 Acrostak (Schweiz) AG
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Product Type, Application and Specification
  7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Business Overview
7.2 Concept Medical Inc
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Product Type, Application and Specification
  7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Business Overview
7.3 Lifetech Scientific
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Product Type, Application and Specification
  7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Business Overview
7.4 Micell Technologies, Inc
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Product Type, Application and Specification
  7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Business Overview
7.5 SurModics, Inc.
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
  7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Business Overview
7.6 The Spectranetics Corporation
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Product Type, Application and Specification
  7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Business Overview
7.7 Vascular Nanotransfer Technologies Company
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Product Type, Application and Specification
  7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Business Overview
7.8 company
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
  7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Business Overview
7.9 company
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
  7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Business Overview

CHAPTER 8 PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON (DEB) CATHETER MANUFACTURING COST ANALYSIS

8.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter

CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Major Manufacturers in 2016
9.4 Downstream Buyers

CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

CHAPTER 12 CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON (DEB) CATHETER MARKET FORECAST (2017-2022)

12.1 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production, Revenue Forecast (2017-2022)
12.2 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production, Consumption Forecast by Regions (2017-2022)
12.3 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production Forecast by Type (2017-2022)
12.4 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Consumption Forecast by Application (2017-2022)
12.5 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Price Forecast (2017-2022)

CHAPTER 13 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter
Figure China Production Market Share of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter by Type in 2016
Table Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Consumption Market Share by Application in 2016
Figure China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Revenue (Million USD) and Growth Rate (2012-2021)
Table China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Capacity of Key Manufacturers (2015 and 2016)
Table China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Capacity of Key Manufacturers in 2015
Figure China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Capacity of Key Manufacturers in 2016
Table China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production of Key Manufacturers (2015 and 2016)
Table China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production Share by Manufacturers (2015 and 2016)
Figure 2015 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production Share by Manufacturers
Figure 2016 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production Share by Manufacturers
Table China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Revenue Share by Manufacturers
Table 2016 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Revenue Share by Manufacturers
Table China Market Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Average Price of Key Manufacturers in 2016
Table Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Manufacturing Base Distribution and Sales Area
Table Manufacturers Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Product Type
Figure Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Share of Top 3 Manufacturers
Figure Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Share (2012-2017)
Table Acrostak (Schweiz) AG Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Acrostak (Schweiz) AG Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production, Revenue, Price and Gross Margin (2012-2017)
Table Acrostak (Schweiz) AG Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Share (2012-2017)
Table Concept Medical Inc Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Concept Medical Inc Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production, Revenue, Price and Gross Margin (2012-2017)
Table Concept Medical Inc Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Share (2012-2017)
Table Lifetech Scientific Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Lifetech Scientific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production, Revenue, Price and Gross Margin (2012-2017)
Table Lifetech Scientific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Share (2012-2017)
Table Micell Technologies, Inc Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Micell Technologies, Inc Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production, Revenue, Price and Gross Margin (2012-2017)
Table Micell Technologies, Inc Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Share (2012-2017)
Table SurModics, Inc. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table SurModics, Inc. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production, Revenue, Price and Gross Margin (2012-2017)
Table SurModics, Inc. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Share (2012-2017)
Table The Spectranetics Corporation Basic Information, Manufacturing Base, Production Area and Its Competitors
Table The Spectranetics Corporation Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production, Revenue, Price and Gross Margin (2012-2017)
Table The Spectranetics Corporation Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Share (2012-2017)
Table Vascular Nanotransfer Technologies Company Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Vascular Nanotransfer Technologies Company Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production, Revenue, Price and Gross Margin (2012-2017)
Table Vascular Nanotransfer Technologies Company Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Share (2012-2017)
Table company 8 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 8 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production, Revenue, Price and Gross Margin (2012-2017)
Table company 8 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Share (2012-2017)
Table company 9 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 9 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production, Revenue, Price and Gross Margin (2012-2017)
Table company 9 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Market Share (2012-2017)
Figure Production Revenue Share of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter by Type (2012-2017)
Figure 2015 Revenue Market Share of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter by Type
Table China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Price by Type (2012-2017)
Figure China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production Growth by Type (2012-2017)
Table China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Consumption by Application (2012-2017)
Table China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Consumption Market Share by Application (2012-2017)
Figure China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Consumption Market Share by Application in 2016
Table China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Consumption Growth Rate by Application (2012-2017)
Figure China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter
Figure Manufacturing Process Analysis of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter
Figure Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Industrial Chain Analysis
Table Raw Materials Sources of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Major Manufacturers in 2015
Table Major Buyers of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter
Table Distributors/Traders List
Figure China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Revenue and Growth Rate Forecast (2017-2022)
Table China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production, Import, Export and Consumption Forecast (2017-2022)
Table China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Production Forecast by Type (2017-2022)
Table China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheter Consumption Forecast by Application (2017-2022)

COMPANIES MENTIONED

Acrostak (Schweiz) AG
Concept Medical Inc
Lifetech Scientific
Micell Technologies, Inc
SurModics, Inc.
The Spectranetics Corporation
Vascular Nanotransfer Technologies Company